• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Argenx - Articles and news items


Argenx announces initial ARGX-113 Phase 1 study results

Industry news / 6 January 2016 / Victoria White

The objective of the Phase 1 study is to evaluate the safety and tolerability of ARGX-113 and to identify a potential dose for future Phase 2 studies…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +